- ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study in women with overweight or obesity to test whether different doses of BI 456906 influence the amount of a contraceptive in the blood
This study is looking at how a new medication (code name BI 456906) affects a common contraceptive in women who are overweight or obese. We want to see if different amounts of the new medicine change how much contraceptive stays in the blood.
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
A study in healthy people to compare two different Sifrol® tablets
This study is looking at two different forms of a medicine called Sifrol®. We want to see if they work the same way in healthy adults. It's an early-stage study to check how the body handles the medicine.
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body
This study looks at how two versions of a new medicine, BI 1015550, are absorbed in the body. It involves healthy volunteers and is an early-stage study to understand how the medicine behaves, ensuring it's taken in by the body as expected. It's not about treating an illness.
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furosemide) in the blood
This study looks at how a new medicine, zongertinib, might affect how your body handles other common medicines like dabigatran, rosuvastatin, metformin, and furosemide. We're testing this in healthy men to see if zongertinib changes the amount of these other medicines in their blood.
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body
This study is looking at how two different strong doses of a new medicine called BI 1015550 are absorbed and used by the body in healthy people. It's an early-stage study to make sure the medicine works as expected.
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood
This study is looking at healthy men to see how a new medicine called zongertinib might affect other medications. It helps us understand how different drugs interact in the body.
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study in healthy women to test whether BI 1358894 influences the amount of a contraceptive in the blood
This study is looking at how a new medicine, BI 1358894, affects a common contraceptive in healthy women. It aims to see if the new medicine changes the amount of contraceptive in the blood, which is important for understanding how medicines work together.
Germany